From the *Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford University Hospitals NHS Foundation Trust, and National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom
†Department of Clinical Laboratory Immunology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
‡Division of Immunology, University Children’s Hospital Zurich and Children’s Research Center, University of Zurich (UZH), Switzerland.
Accepted for publication March 11, 2022
The authors have no funding or conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Else M. Bijker, MD, PhD, Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Department of Paediatrics, Churchill Hospital, University of Oxford, Old Road, Headington, OX3 7LE Oxford, United Kingdom. E-mail: [email protected].
